• Home
• core 10 scoring
• Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates - Research and Practice in Thrombosis and Haemostasis

Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates - Research and Practice in Thrombosis and Haemostasis

4.6 (664) · $ 15.50 · In stock

PDF) The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B

Patients' and health care providers' perspectives on quality of

Saunya Dover's research works SickKids, Toronto and other places

Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐ KLAT) in the era of extended half‐life clotting factor concentrates - Price - 2021 - Research and Practice in Thrombosis and Haemostasis - Wiley

PDF) Guidelines for the management of hemophilia Kathy Mulder, J. Mahlangu, and Nigel Key

Hemophilia treatment options

Hemophilia Steps for Living

Thrombin generation and implications for hemophilia therapies: A narrative review - Research and Practice in Thrombosis and Haemostasis

Updating the Canadian hemophilia outcomes-kids life assessment tool (CHO- KLAT Version2.0).